

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.89809298 |
| 2 | proteasome assembly (GO:0043248) | 4.67006908 |
| 3 | regulation of translational termination (GO:0006449) | 4.51495286 |
| 4 | rRNA methylation (GO:0031167) | 4.21644046 |
| 5 | glycine metabolic process (GO:0006544) | 4.02334669 |
| 6 | transcription from mitochondrial promoter (GO:0006390) | 4.00638421 |
| 7 | rRNA modification (GO:0000154) | 4.00478014 |
| 8 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 3.97932308 |
| 9 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 3.97932308 |
| 10 | isotype switching (GO:0045190) | 3.97932308 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 3.93481667 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.93481667 |
| 13 | serine family amino acid biosynthetic process (GO:0009070) | 3.90517931 |
| 14 | L-phenylalanine catabolic process (GO:0006559) | 3.83736861 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.83736861 |
| 16 | cysteine metabolic process (GO:0006534) | 3.82756492 |
| 17 | maturation of 5.8S rRNA (GO:0000460) | 3.80517049 |
| 18 | one-carbon metabolic process (GO:0006730) | 3.74414795 |
| 19 | mitochondrial RNA metabolic process (GO:0000959) | 3.73035941 |
| 20 | cullin deneddylation (GO:0010388) | 3.72210059 |
| 21 | protein deneddylation (GO:0000338) | 3.65875279 |
| 22 | * folic acid metabolic process (GO:0046655) | 3.65633512 |
| 23 | tRNA aminoacylation for protein translation (GO:0006418) | 3.65086816 |
| 24 | tRNA aminoacylation (GO:0043039) | 3.61931438 |
| 25 | amino acid activation (GO:0043038) | 3.61931438 |
| 26 | tetrahydrofolate metabolic process (GO:0046653) | 3.61273195 |
| 27 | L-serine metabolic process (GO:0006563) | 3.59264975 |
| 28 | pore complex assembly (GO:0046931) | 3.57805602 |
| 29 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.55990940 |
| 30 | mitotic metaphase plate congression (GO:0007080) | 3.53533567 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.49909063 |
| 32 | pseudouridine synthesis (GO:0001522) | 3.47143110 |
| 33 | aromatic amino acid family catabolic process (GO:0009074) | 3.46782479 |
| 34 | serine family amino acid metabolic process (GO:0009069) | 3.46110303 |
| 35 | urea cycle (GO:0000050) | 3.45869874 |
| 36 | urea metabolic process (GO:0019627) | 3.45869874 |
| 37 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 3.45074074 |
| 38 | negative regulation of fibrinolysis (GO:0051918) | 3.41759266 |
| 39 | alpha-linolenic acid metabolic process (GO:0036109) | 3.33429705 |
| 40 | regulation of centriole replication (GO:0046599) | 3.31875617 |
| 41 | metaphase plate congression (GO:0051310) | 3.31643693 |
| 42 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.27459835 |
| 43 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.26510002 |
| 44 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.25732982 |
| 45 | somatic diversification of immunoglobulins (GO:0016445) | 3.22103262 |
| 46 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.21926381 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 3.21489844 |
| 48 | * folic acid-containing compound metabolic process (GO:0006760) | 3.19094572 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 3.18871962 |
| 50 | protein carboxylation (GO:0018214) | 3.17539158 |
| 51 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.17539158 |
| 52 | kynurenine metabolic process (GO:0070189) | 3.16491510 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 3.16386545 |
| 54 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.16029847 |
| 55 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.15911673 |
| 56 | protein K6-linked ubiquitination (GO:0085020) | 3.15146329 |
| 57 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.13380121 |
| 58 | termination of RNA polymerase I transcription (GO:0006363) | 3.13225994 |
| 59 | DNA double-strand break processing (GO:0000729) | 3.11574745 |
| 60 | ribonucleoprotein complex disassembly (GO:0032988) | 3.11479862 |
| 61 | indole-containing compound catabolic process (GO:0042436) | 3.10425794 |
| 62 | indolalkylamine catabolic process (GO:0046218) | 3.10425794 |
| 63 | tryptophan catabolic process (GO:0006569) | 3.10425794 |
| 64 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.10136142 |
| 65 | non-recombinational repair (GO:0000726) | 3.10136142 |
| 66 | lysine catabolic process (GO:0006554) | 3.08812381 |
| 67 | lysine metabolic process (GO:0006553) | 3.08812381 |
| 68 | nucleobase biosynthetic process (GO:0046112) | 3.08631798 |
| 69 | bile acid biosynthetic process (GO:0006699) | 3.08344743 |
| 70 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.05998419 |
| 71 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.04911925 |
| 72 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.04911925 |
| 73 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.04911925 |
| 74 | regulation of protein activation cascade (GO:2000257) | 3.03353145 |
| 75 | purine nucleobase biosynthetic process (GO:0009113) | 3.02844899 |
| 76 | establishment of chromosome localization (GO:0051303) | 3.02203369 |
| 77 | negative regulation of ligase activity (GO:0051352) | 3.01274116 |
| 78 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.01274116 |
| 79 | valine metabolic process (GO:0006573) | 3.01088397 |
| 80 | protein localization to chromosome, centromeric region (GO:0071459) | 3.00200825 |
| 81 | regulation of fibrinolysis (GO:0051917) | 2.97598290 |
| 82 | tryptophan metabolic process (GO:0006568) | 2.97290095 |
| 83 | imidazole-containing compound metabolic process (GO:0052803) | 2.94744903 |
| 84 | nuclear pore complex assembly (GO:0051292) | 2.94272673 |
| 85 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.93125099 |
| 86 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.90892652 |
| 87 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.88638217 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.88638217 |
| 89 | rRNA processing (GO:0006364) | 2.87154652 |
| 90 | COPII vesicle coating (GO:0048208) | 2.87018893 |
| 91 | peptidyl-histidine modification (GO:0018202) | 2.86309721 |
| 92 | mitotic nuclear envelope disassembly (GO:0007077) | 2.85709771 |
| 93 | homocysteine metabolic process (GO:0050667) | 2.85545594 |
| 94 | organelle disassembly (GO:1903008) | 2.84159179 |
| 95 | regulation of complement activation (GO:0030449) | 2.83591033 |
| 96 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.83510305 |
| 97 | nuclear pore organization (GO:0006999) | 2.83451278 |
| 98 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.83132511 |
| 99 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.82773055 |
| 100 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.82773055 |
| 101 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.82364880 |
| 102 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.82364880 |
| 103 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.82364880 |
| 104 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.82030652 |
| 105 | * pteridine-containing compound metabolic process (GO:0042558) | 2.81916959 |
| 106 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.80725580 |
| 107 | protein K11-linked ubiquitination (GO:0070979) | 2.80708129 |
| 108 | regulation of DNA endoreduplication (GO:0032875) | 2.80600309 |
| 109 | DNA deamination (GO:0045006) | 2.80048962 |
| 110 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.80036775 |
| 111 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.80036775 |
| 112 | positive regulation of ligase activity (GO:0051351) | 2.79952379 |
| 113 | response to pheromone (GO:0019236) | 2.79828173 |
| 114 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.79713129 |
| 115 | mitotic sister chromatid cohesion (GO:0007064) | 2.79645610 |
| 116 | magnesium ion transport (GO:0015693) | 2.78459920 |
| 117 | complement activation, alternative pathway (GO:0006957) | 2.78446777 |
| 118 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.78424854 |
| 119 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.78424854 |
| 120 | tRNA metabolic process (GO:0006399) | 2.78032235 |
| 121 | amino-acid betaine metabolic process (GO:0006577) | 2.77872459 |
| 122 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.77740000 |
| 123 | glyoxylate metabolic process (GO:0046487) | 2.77508473 |
| 124 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.76955697 |
| 125 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.76622540 |
| 126 | rRNA metabolic process (GO:0016072) | 2.75808495 |
| 127 | high-density lipoprotein particle remodeling (GO:0034375) | 2.75453355 |
| 128 | ER overload response (GO:0006983) | 2.75391600 |
| 129 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.74032332 |
| 130 | sulfur amino acid biosynthetic process (GO:0000097) | 2.73120888 |
| 131 | bile acid metabolic process (GO:0008206) | 2.72443230 |
| 132 | regulation of mitochondrial translation (GO:0070129) | 2.72429615 |
| 133 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.72345934 |
| 134 | 7-methylguanosine mRNA capping (GO:0006370) | 2.70229898 |
| 135 | establishment of integrated proviral latency (GO:0075713) | 2.69612495 |
| 136 | mitochondrial DNA replication (GO:0006264) | 2.69123412 |
| 137 | regulation of centrosome cycle (GO:0046605) | 2.69056370 |
| 138 | formation of translation preinitiation complex (GO:0001731) | 2.68538642 |
| 139 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.68385799 |
| 140 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.68385799 |
| 141 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.68214516 |
| 142 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.68214516 |
| 143 | ribosome assembly (GO:0042255) | 2.66826750 |
| 144 | membrane disassembly (GO:0030397) | 2.66312779 |
| 145 | nuclear envelope disassembly (GO:0051081) | 2.66312779 |
| 146 | aromatic amino acid family metabolic process (GO:0009072) | 2.64561030 |
| 147 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.64230472 |
| 148 | response to X-ray (GO:0010165) | 2.64095042 |
| 149 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.63166293 |
| 150 | negative regulation of sterol transport (GO:0032372) | 2.62870634 |
| 151 | negative regulation of cholesterol transport (GO:0032375) | 2.62870634 |
| 152 | regulation of cholesterol homeostasis (GO:2000188) | 2.62507072 |
| 153 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.60481453 |
| 154 | bile acid and bile salt transport (GO:0015721) | 2.58587509 |
| 155 | triglyceride homeostasis (GO:0070328) | 2.58464353 |
| 156 | acylglycerol homeostasis (GO:0055090) | 2.58464353 |
| 157 | ribosome biogenesis (GO:0042254) | 2.57014584 |
| 158 | sulfur amino acid metabolic process (GO:0000096) | 2.56750659 |
| 159 | nucleoside salvage (GO:0043174) | 2.55308676 |
| 160 | 2-oxoglutarate metabolic process (GO:0006103) | 2.53812991 |
| 161 | tyrosine metabolic process (GO:0006570) | 2.51320756 |
| 162 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.50208183 |
| 163 | alpha-amino acid catabolic process (GO:1901606) | 2.50156339 |
| 164 | regulation of triglyceride catabolic process (GO:0010896) | 2.49782925 |
| 165 | IMP biosynthetic process (GO:0006188) | 2.49748040 |
| 166 | cellular glucuronidation (GO:0052695) | 2.48411791 |
| 167 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.47802183 |
| 168 | UMP metabolic process (GO:0046049) | 2.47802183 |
| 169 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.47802183 |
| 170 | UMP biosynthetic process (GO:0006222) | 2.47802183 |
| 171 | ethanol oxidation (GO:0006069) | 2.46597055 |
| 172 | IMP metabolic process (GO:0046040) | 2.46399114 |
| 173 | alpha-amino acid biosynthetic process (GO:1901607) | 2.45154798 |
| 174 | protein localization to kinetochore (GO:0034501) | 2.44526167 |
| 175 | DNA replication initiation (GO:0006270) | 2.42955256 |
| 176 | pantothenate metabolic process (GO:0015939) | 2.41764454 |
| 177 | protein-lipid complex remodeling (GO:0034368) | 2.40523224 |
| 178 | macromolecular complex remodeling (GO:0034367) | 2.40523224 |
| 179 | plasma lipoprotein particle remodeling (GO:0034369) | 2.40523224 |
| 180 | regulation of spindle organization (GO:0090224) | 2.40501682 |
| 181 | methionine metabolic process (GO:0006555) | 2.38830497 |
| 182 | plasma lipoprotein particle clearance (GO:0034381) | 2.38491334 |
| 183 | AMP metabolic process (GO:0046033) | 2.37622277 |
| 184 | plasma lipoprotein particle assembly (GO:0034377) | 2.37588775 |
| 185 | urate metabolic process (GO:0046415) | 2.35071351 |
| 186 | reverse cholesterol transport (GO:0043691) | 2.33247363 |
| 187 | maturation of SSU-rRNA (GO:0030490) | 2.32949253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.65594696 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.68139768 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.27959843 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.22868416 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.16553378 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.89371291 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.71512193 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.46870009 |
| 9 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.39911864 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.33654716 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.29085838 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.27206397 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.24575634 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24419154 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.21829558 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.19985872 |
| 17 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.16243321 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.09891219 |
| 19 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.97123446 |
| 20 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.97001220 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.94486965 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.90332202 |
| 23 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88734873 |
| 24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88062384 |
| 25 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.87082605 |
| 26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.84740036 |
| 27 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.83910239 |
| 28 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.83788628 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.83643600 |
| 30 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.76867980 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.75244629 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.72801961 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70391506 |
| 34 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68571820 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.68471696 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67668596 |
| 37 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63113160 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58802562 |
| 39 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.58587542 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55489841 |
| 41 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.55140949 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54831841 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54522776 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54071009 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53844246 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52671879 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.49028595 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47023432 |
| 49 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46513238 |
| 50 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.46207402 |
| 51 | EWS_26573619_Chip-Seq_HEK293_Human | 1.43524499 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42720610 |
| 53 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.42419055 |
| 54 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.41768644 |
| 55 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.41458972 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.40529054 |
| 57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40397412 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40073686 |
| 59 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39865509 |
| 60 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39803874 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.38617209 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.36453735 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.35709075 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34893103 |
| 65 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.33995870 |
| 66 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31818310 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.30220494 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.29362959 |
| 69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29323206 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29264919 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28773850 |
| 72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25679495 |
| 73 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.25207076 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.24965752 |
| 75 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.24534281 |
| 76 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.22547619 |
| 77 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22313902 |
| 78 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18471412 |
| 79 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.18062298 |
| 80 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.16901763 |
| 81 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.15527600 |
| 82 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14149447 |
| 83 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.14127905 |
| 84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12979925 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11175067 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10621332 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09316310 |
| 88 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.07781742 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.07525198 |
| 90 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06566678 |
| 91 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.05977946 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05932037 |
| 93 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02494902 |
| 94 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01415842 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.00147326 |
| 96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00061071 |
| 97 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98269717 |
| 98 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98193718 |
| 99 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.97911899 |
| 100 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.97889276 |
| 101 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97107217 |
| 102 | MYB_26560356_Chip-Seq_TH2_Human | 0.96996337 |
| 103 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.96919239 |
| 104 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.96507518 |
| 105 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96329538 |
| 106 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.96132154 |
| 107 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95415112 |
| 108 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.95085560 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93990031 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93199639 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93104040 |
| 112 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92909443 |
| 113 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.92727942 |
| 114 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92696650 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92696650 |
| 116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91787341 |
| 117 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.91746158 |
| 118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91538631 |
| 119 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91506780 |
| 120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91499336 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90933555 |
| 122 | UTX_26944678_Chip-Seq_JUKART_Human | 0.89844527 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89550963 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89527449 |
| 125 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89014243 |
| 126 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88640885 |
| 127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87988903 |
| 128 | MAF_26560356_Chip-Seq_TH1_Human | 0.87674163 |
| 129 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86340525 |
| 130 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.85044717 |
| 131 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.84910506 |
| 132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84591613 |
| 133 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.84358548 |
| 134 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.83828891 |
| 135 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82738811 |
| 136 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.82716420 |
| 137 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81621705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.62933731 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.61890746 |
| 3 | MP0005365_abnormal_bile_salt | 4.07530619 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.67527727 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.54576252 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.21579046 |
| 7 | MP0003786_premature_aging | 2.97274058 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.91161020 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.52112659 |
| 10 | MP0003252_abnormal_bile_duct | 2.48313988 |
| 11 | MP0009840_abnormal_foam_cell | 2.37288400 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.11262098 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.07991730 |
| 14 | MP0004957_abnormal_blastocyst_morpholog | 1.97674004 |
| 15 | MP0010329_abnormal_lipoprotein_level | 1.92340450 |
| 16 | MP0003221_abnormal_cardiomyocyte_apopto | 1.86412735 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 1.81474974 |
| 18 | MP0002396_abnormal_hematopoietic_system | 1.78979290 |
| 19 | MP0000609_abnormal_liver_physiology | 1.78508995 |
| 20 | MP0005083_abnormal_biliary_tract | 1.75294428 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.74258805 |
| 22 | MP0002102_abnormal_ear_morphology | 1.66019213 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 1.65831772 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.57337570 |
| 25 | MP0006035_abnormal_mitochondrial_morpho | 1.55012044 |
| 26 | MP0000358_abnormal_cell_content/ | 1.54813888 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.53268570 |
| 28 | MP0005332_abnormal_amino_acid | 1.50638428 |
| 29 | MP0003186_abnormal_redox_activity | 1.49542680 |
| 30 | MP0003111_abnormal_nucleus_morphology | 1.46817773 |
| 31 | MP0005379_endocrine/exocrine_gland_phen | 1.45305433 |
| 32 | MP0003077_abnormal_cell_cycle | 1.44950877 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 1.44481471 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.44437805 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.43859070 |
| 36 | MP0000427_abnormal_hair_cycle | 1.43740458 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.39125825 |
| 38 | MP0003868_abnormal_feces_composition | 1.36986305 |
| 39 | MP0001529_abnormal_vocalization | 1.35168983 |
| 40 | MP0003718_maternal_effect | 1.34190358 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.33306580 |
| 42 | MP0002254_reproductive_system_inflammat | 1.32318567 |
| 43 | MP0006054_spinal_hemorrhage | 1.31548923 |
| 44 | MP0001697_abnormal_embryo_size | 1.28785790 |
| 45 | MP0001853_heart_inflammation | 1.28684651 |
| 46 | MP0002132_abnormal_respiratory_system | 1.28619915 |
| 47 | MP0000685_abnormal_immune_system | 1.28319755 |
| 48 | MP0000598_abnormal_liver_morphology | 1.27971861 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.27520048 |
| 50 | MP0010307_abnormal_tumor_latency | 1.27336438 |
| 51 | MP0001727_abnormal_embryo_implantation | 1.26092790 |
| 52 | MP0003436_decreased_susceptibility_to | 1.24421565 |
| 53 | MP0008438_abnormal_cutaneous_collagen | 1.24151269 |
| 54 | MP0002163_abnormal_gland_morphology | 1.22477834 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.21785684 |
| 56 | MP0001348_abnormal_lacrimal_gland | 1.20707440 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.20638047 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.19595257 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.18529756 |
| 60 | MP0001672_abnormal_embryogenesis/_devel | 1.17481399 |
| 61 | MP0005380_embryogenesis_phenotype | 1.17481399 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.17306232 |
| 63 | MP0003890_abnormal_embryonic-extraembry | 1.17216200 |
| 64 | MP0000372_irregular_coat_pigmentation | 1.14865582 |
| 65 | MP0002160_abnormal_reproductive_system | 1.14053550 |
| 66 | MP0005023_abnormal_wound_healing | 1.13508267 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 1.13094548 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 1.12515729 |
| 69 | MP0008057_abnormal_DNA_replication | 1.09695635 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 1.08457463 |
| 71 | MP0008007_abnormal_cellular_replicative | 1.07901610 |
| 72 | MP0003984_embryonic_growth_retardation | 1.07266623 |
| 73 | MP0001730_embryonic_growth_arrest | 1.06034300 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.05914946 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.05914946 |
| 76 | MP0000569_abnormal_digit_pigmentation | 1.05183913 |
| 77 | MP0002088_abnormal_embryonic_growth/wei | 1.04566988 |
| 78 | MP0002877_abnormal_melanocyte_morpholog | 1.03035653 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 1.02351484 |
| 80 | MP0000490_abnormal_crypts_of | 1.01678159 |
| 81 | MP0008469_abnormal_protein_level | 1.00286804 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.99478373 |
| 83 | MP0009697_abnormal_copulation | 0.99338636 |
| 84 | MP0000350_abnormal_cell_proliferation | 0.98792423 |
| 85 | MP0005389_reproductive_system_phenotype | 0.98441009 |
| 86 | MP0009763_increased_sensitivity_to | 0.97969614 |
| 87 | MP0001191_abnormal_skin_condition | 0.97435253 |
| 88 | MP0001542_abnormal_bone_strength | 0.96857102 |
| 89 | MP0000313_abnormal_cell_death | 0.96380502 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.96076954 |
| 91 | MP0001835_abnormal_antigen_presentation | 0.96048536 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.95934622 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.95764339 |
| 94 | MP0008877_abnormal_DNA_methylation | 0.94960932 |
| 95 | MP0002398_abnormal_bone_marrow | 0.93937782 |
| 96 | MP0001800_abnormal_humoral_immune | 0.93910423 |
| 97 | MP0001764_abnormal_homeostasis | 0.93268835 |
| 98 | MP0005384_cellular_phenotype | 0.92253787 |
| 99 | MP0002722_abnormal_immune_system | 0.92106238 |
| 100 | MP0002086_abnormal_extraembryonic_tissu | 0.91619131 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.90700499 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 0.89339445 |
| 103 | MP0005408_hypopigmentation | 0.88748431 |
| 104 | MP0003195_calcinosis | 0.88523228 |
| 105 | MP0009643_abnormal_urine_homeostasis | 0.88185845 |
| 106 | MP0005451_abnormal_body_composition | 0.87099117 |
| 107 | MP0005076_abnormal_cell_differentiation | 0.87004903 |
| 108 | MP0003724_increased_susceptibility_to | 0.85854010 |
| 109 | MP0005621_abnormal_cell_physiology | 0.85431170 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.84961684 |
| 111 | MP0002009_preneoplasia | 0.84566783 |
| 112 | MP0005670_abnormal_white_adipose | 0.84410791 |
| 113 | MP0005671_abnormal_response_to | 0.83978716 |
| 114 | MP0002405_respiratory_system_inflammati | 0.83585957 |
| 115 | MP0001243_abnormal_dermal_layer | 0.83214936 |
| 116 | MP0001919_abnormal_reproductive_system | 0.82752503 |
| 117 | MP0002084_abnormal_developmental_patter | 0.82576758 |
| 118 | MP0002933_joint_inflammation | 0.82443416 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.82380883 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82026868 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.81559418 |
| 122 | MP0004233_abnormal_muscle_weight | 0.81142556 |
| 123 | MP0006082_CNS_inflammation | 0.80957534 |
| 124 | MP0001661_extended_life_span | 0.80898317 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.80481240 |
| 126 | MP0008058_abnormal_DNA_repair | 0.80441393 |
| 127 | MP0004019_abnormal_vitamin_homeostasis | 0.80348464 |
| 128 | MP0005666_abnormal_adipose_tissue | 0.80238507 |
| 129 | MP0005257_abnormal_intraocular_pressure | 0.80176645 |
| 130 | MP0004197_abnormal_fetal_growth/weight/ | 0.79947572 |
| 131 | MP0004272_abnormal_basement_membrane | 0.79340061 |
| 132 | MP0001873_stomach_inflammation | 0.78461659 |
| 133 | MP0005266_abnormal_metabolism | 0.78360435 |
| 134 | MP0000371_diluted_coat_color | 0.78315966 |
| 135 | MP0001216_abnormal_epidermal_layer | 0.77903803 |
| 136 | MP0010155_abnormal_intestine_physiology | 0.77560668 |
| 137 | MP0002006_tumorigenesis | 0.77483871 |
| 138 | MP0002429_abnormal_blood_cell | 0.76663240 |
| 139 | MP0002060_abnormal_skin_morphology | 0.76323105 |
| 140 | MP0002452_abnormal_antigen_presenting | 0.76203236 |
| 141 | MP0000716_abnormal_immune_system | 0.75753248 |
| 142 | MP0001188_hyperpigmentation | 0.74617294 |
| 143 | MP0004947_skin_inflammation | 0.74549345 |
| 144 | MP0002723_abnormal_immune_serum | 0.73837838 |
| 145 | MP0003943_abnormal_hepatobiliary_system | 0.73662625 |
| 146 | MP0009764_decreased_sensitivity_to | 0.73511514 |
| 147 | MP0005395_other_phenotype | 0.72089083 |
| 148 | MP0000703_abnormal_thymus_morphology | 0.71817625 |
| 149 | MP0001533_abnormal_skeleton_physiology | 0.71731946 |
| 150 | MP0001881_abnormal_mammary_gland | 0.71586707 |
| 151 | MP0004134_abnormal_chest_morphology | 0.70832074 |
| 152 | MP0002080_prenatal_lethality | 0.70272665 |
| 153 | MP0010678_abnormal_skin_adnexa | 0.70232564 |
| 154 | MP0001929_abnormal_gametogenesis | 0.70158309 |
| 155 | MP0000647_abnormal_sebaceous_gland | 0.69972483 |
| 156 | MP0001119_abnormal_female_reproductive | 0.69792596 |
| 157 | MP0003937_abnormal_limbs/digits/tail_de | 0.68907451 |
| 158 | MP0002210_abnormal_sex_determination | 0.67565449 |
| 159 | MP0005165_increased_susceptibility_to | 0.66089920 |
| 160 | MP0004782_abnormal_surfactant_physiolog | 0.65937017 |
| 161 | MP0005084_abnormal_gallbladder_morpholo | 0.65436850 |
| 162 | MP0000015_abnormal_ear_pigmentation | 0.63572579 |
| 163 | MP0002177_abnormal_outer_ear | 0.63084003 |
| 164 | MP0000627_abnormal_mammary_gland | 0.62441875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.76335656 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 4.71574178 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.67469823 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.62933604 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.62253940 |
| 6 | Xanthomatosis (HP:0000991) | 4.19328232 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 3.65827413 |
| 8 | Hypolipoproteinemia (HP:0010981) | 3.53092509 |
| 9 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.38649336 |
| 10 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33461571 |
| 11 | Cutaneous melanoma (HP:0012056) | 3.33052558 |
| 12 | Chromsome breakage (HP:0040012) | 3.24192697 |
| 13 | Abnormality of chromosome stability (HP:0003220) | 3.23070006 |
| 14 | Abnormal protein glycosylation (HP:0012346) | 3.22747904 |
| 15 | Abnormal glycosylation (HP:0012345) | 3.22747904 |
| 16 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.22747904 |
| 17 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.22747904 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 3.19111743 |
| 19 | Hyperammonemia (HP:0001987) | 3.17425868 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.14348203 |
| 21 | Abnormality of the preputium (HP:0100587) | 3.07848823 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.04074795 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 3.01763535 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 2.94047435 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 2.93836988 |
| 26 | Tongue fasciculations (HP:0001308) | 2.90214643 |
| 27 | Microvesicular hepatic steatosis (HP:0001414) | 2.90038864 |
| 28 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.89676269 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.87082777 |
| 30 | Myocardial infarction (HP:0001658) | 2.83561724 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.82878030 |
| 32 | Fat malabsorption (HP:0002630) | 2.82807698 |
| 33 | Progressive inability to walk (HP:0002505) | 2.77261670 |
| 34 | Type I transferrin isoform profile (HP:0003642) | 2.75233844 |
| 35 | Complement deficiency (HP:0004431) | 2.72812968 |
| 36 | Increased serum lactate (HP:0002151) | 2.72812956 |
| 37 | Abnormality of the anterior horn cell (HP:0006802) | 2.71771140 |
| 38 | Degeneration of anterior horn cells (HP:0002398) | 2.71771140 |
| 39 | Meckel diverticulum (HP:0002245) | 2.70572744 |
| 40 | Abnormal cartilage morphology (HP:0002763) | 2.65900464 |
| 41 | Progressive external ophthalmoplegia (HP:0000590) | 2.64260383 |
| 42 | Sensory axonal neuropathy (HP:0003390) | 2.61848701 |
| 43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60128784 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.59253884 |
| 45 | Acanthocytosis (HP:0001927) | 2.58309621 |
| 46 | Increased hepatocellular lipid droplets (HP:0006565) | 2.58274579 |
| 47 | Hyperglycinemia (HP:0002154) | 2.56147582 |
| 48 | Abnormality of the ileum (HP:0001549) | 2.55292901 |
| 49 | Hyperglycinuria (HP:0003108) | 2.54375277 |
| 50 | Ketosis (HP:0001946) | 2.52817326 |
| 51 | Entropion (HP:0000621) | 2.52750924 |
| 52 | Hyperbilirubinemia (HP:0002904) | 2.51161437 |
| 53 | Epidermoid cyst (HP:0200040) | 2.48802917 |
| 54 | Progressive muscle weakness (HP:0003323) | 2.48434141 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 2.47683812 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.47683812 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.46689197 |
| 58 | Increased CSF lactate (HP:0002490) | 2.45279359 |
| 59 | Birth length less than 3rd percentile (HP:0003561) | 2.44345423 |
| 60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.43293478 |
| 61 | Joint hemorrhage (HP:0005261) | 2.42722515 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 2.42701024 |
| 63 | Abnormality of the pons (HP:0007361) | 2.39373260 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.33263154 |
| 65 | Multiple enchondromatosis (HP:0005701) | 2.32514800 |
| 66 | Duodenal stenosis (HP:0100867) | 2.31946687 |
| 67 | Small intestinal stenosis (HP:0012848) | 2.31946687 |
| 68 | Thrombocytosis (HP:0001894) | 2.31734269 |
| 69 | Upper limb muscle weakness (HP:0003484) | 2.30770772 |
| 70 | Abnormality of nucleobase metabolism (HP:0010932) | 2.30177577 |
| 71 | Hypokinesia (HP:0002375) | 2.27684254 |
| 72 | Spastic diplegia (HP:0001264) | 2.24821952 |
| 73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.23994032 |
| 74 | Oral leukoplakia (HP:0002745) | 2.22889952 |
| 75 | Acute encephalopathy (HP:0006846) | 2.21916449 |
| 76 | Acute necrotizing encephalopathy (HP:0006965) | 2.20633368 |
| 77 | Muscle fibrillation (HP:0010546) | 2.20032252 |
| 78 | Rough bone trabeculation (HP:0100670) | 2.19995564 |
| 79 | Myelodysplasia (HP:0002863) | 2.19256890 |
| 80 | Renal cortical cysts (HP:0000803) | 2.19148099 |
| 81 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.17751764 |
| 82 | Progressive macrocephaly (HP:0004481) | 2.16637284 |
| 83 | Hypercholesterolemia (HP:0003124) | 2.16024102 |
| 84 | 3-Methylglutaconic aciduria (HP:0003535) | 2.14313977 |
| 85 | Abnormality of complement system (HP:0005339) | 2.11786987 |
| 86 | Rhabdomyosarcoma (HP:0002859) | 2.11028067 |
| 87 | Protrusio acetabuli (HP:0003179) | 2.10023447 |
| 88 | Posterior subcapsular cataract (HP:0007787) | 2.08636286 |
| 89 | Spontaneous abortion (HP:0005268) | 2.07647023 |
| 90 | Poikiloderma (HP:0001029) | 2.07604957 |
| 91 | Abnormality of the umbilical cord (HP:0010881) | 2.06064279 |
| 92 | Breast carcinoma (HP:0003002) | 2.04931907 |
| 93 | Abnormality of purine metabolism (HP:0004352) | 2.03827350 |
| 94 | Clubbing of toes (HP:0100760) | 2.03468832 |
| 95 | Beaking of vertebral bodies (HP:0004568) | 2.02838252 |
| 96 | Lactic acidosis (HP:0003128) | 2.02048096 |
| 97 | Abnormality of iron homeostasis (HP:0011031) | 2.01497346 |
| 98 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.99994696 |
| 99 | Poikilocytosis (HP:0004447) | 1.99730171 |
| 100 | Ureteral duplication (HP:0000073) | 1.99437638 |
| 101 | Steatorrhea (HP:0002570) | 1.99336827 |
| 102 | Increased mean platelet volume (HP:0011877) | 1.98661972 |
| 103 | Abnormality of glycolysis (HP:0004366) | 1.98496867 |
| 104 | Metaphyseal dysplasia (HP:0100255) | 1.98110198 |
| 105 | Abnormality of the duodenum (HP:0002246) | 1.97365867 |
| 106 | Shoulder girdle muscle weakness (HP:0003547) | 1.97282899 |
| 107 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.96377275 |
| 108 | Hypoplasia of the pons (HP:0012110) | 1.95528671 |
| 109 | Abnormal foot bone ossification (HP:0010675) | 1.95499216 |
| 110 | Thrombophlebitis (HP:0004418) | 1.94712904 |
| 111 | Sloping forehead (HP:0000340) | 1.94041705 |
| 112 | Ependymoma (HP:0002888) | 1.93323984 |
| 113 | Aplastic anemia (HP:0001915) | 1.93214655 |
| 114 | Pancytopenia (HP:0001876) | 1.92282521 |
| 115 | Hypothermia (HP:0002045) | 1.92128817 |
| 116 | Abnormality of T cell physiology (HP:0011840) | 1.91778565 |
| 117 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.90946118 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.90185125 |
| 119 | Gingival bleeding (HP:0000225) | 1.89800559 |
| 120 | Glioma (HP:0009733) | 1.89238406 |
| 121 | Hypergonadotropic hypogonadism (HP:0000815) | 1.89141223 |
| 122 | Breast hypoplasia (HP:0003187) | 1.88824763 |
| 123 | Methylmalonic acidemia (HP:0002912) | 1.88430547 |
| 124 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.88350622 |
| 125 | Postnatal microcephaly (HP:0005484) | 1.87542445 |
| 126 | Skin nodule (HP:0200036) | 1.87448372 |
| 127 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.87251645 |
| 128 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.85743623 |
| 129 | Sparse eyelashes (HP:0000653) | 1.85148767 |
| 130 | Hyperglycemia (HP:0003074) | 1.85064288 |
| 131 | Prominent metopic ridge (HP:0005487) | 1.84698654 |
| 132 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.83928797 |
| 133 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.83928797 |
| 134 | Adrenal hypoplasia (HP:0000835) | 1.83810645 |
| 135 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.82885379 |
| 136 | Single umbilical artery (HP:0001195) | 1.82885379 |
| 137 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.82885379 |
| 138 | Cupped ribs (HP:0000887) | 1.81753133 |
| 139 | Abnormality of the carotid arteries (HP:0005344) | 1.81222906 |
| 140 | Deep philtrum (HP:0002002) | 1.80775509 |
| 141 | Carpal bone hypoplasia (HP:0001498) | 1.80620786 |
| 142 | Insidious onset (HP:0003587) | 1.80428406 |
| 143 | Termporal pattern (HP:0011008) | 1.80428406 |
| 144 | Orthostatic hypotension (HP:0001278) | 1.79432788 |
| 145 | Tetraparesis (HP:0002273) | 1.78997698 |
| 146 | Delayed CNS myelination (HP:0002188) | 1.78884981 |
| 147 | Secondary amenorrhea (HP:0000869) | 1.78751968 |
| 148 | Cerebral edema (HP:0002181) | 1.78433298 |
| 149 | Abnormality of the Achilles tendon (HP:0005109) | 1.77616883 |
| 150 | Mitochondrial inheritance (HP:0001427) | 1.76347191 |
| 151 | Increased serum pyruvate (HP:0003542) | 1.75104024 |
| 152 | Pelvic girdle muscle weakness (HP:0003749) | 1.74478488 |
| 153 | Arteriovenous malformation (HP:0100026) | 1.74293028 |
| 154 | Ketoacidosis (HP:0001993) | 1.73567992 |
| 155 | IgG deficiency (HP:0004315) | 1.73457959 |
| 156 | Brittle hair (HP:0002299) | 1.73455442 |
| 157 | Abnormality of T cell number (HP:0011839) | 1.72669253 |
| 158 | Abnormality of the astrocytes (HP:0100707) | 1.72616012 |
| 159 | Astrocytoma (HP:0009592) | 1.72616012 |
| 160 | Abnormality of alanine metabolism (HP:0010916) | 1.72580342 |
| 161 | Hyperalaninemia (HP:0003348) | 1.72580342 |
| 162 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.72580342 |
| 163 | Pancreatitis (HP:0001733) | 1.72323801 |
| 164 | Delayed gross motor development (HP:0002194) | 1.72278944 |
| 165 | Abnormal tarsal ossification (HP:0008369) | 1.72205573 |
| 166 | Irregular epiphyses (HP:0010582) | 1.72014026 |
| 167 | Osteolytic defects of the hand bones (HP:0009699) | 1.71827647 |
| 168 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71827647 |
| 169 | Melanoma (HP:0002861) | 1.71779448 |
| 170 | Peritonitis (HP:0002586) | 1.71597735 |
| 171 | T lymphocytopenia (HP:0005403) | 1.71524476 |
| 172 | Abnormality of T cells (HP:0002843) | 1.71055213 |
| 173 | IgM deficiency (HP:0002850) | 1.70670328 |
| 174 | Reticulocytosis (HP:0001923) | 1.70586458 |
| 175 | Increased serum ferritin (HP:0003281) | 1.67506030 |
| 176 | Megaloblastic anemia (HP:0001889) | 1.66844106 |
| 177 | Epistaxis (HP:0000421) | 1.65795671 |
| 178 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.65751343 |
| 179 | Dicarboxylic aciduria (HP:0003215) | 1.65751343 |
| 180 | Reduced antithrombin III activity (HP:0001976) | 1.64369036 |
| 181 | Squamous cell carcinoma (HP:0002860) | 1.64183268 |
| 182 | Microretrognathia (HP:0000308) | 1.63215535 |
| 183 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.62704976 |
| 184 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.62117578 |
| 185 | Esophageal varix (HP:0002040) | 1.61690638 |
| 186 | Hypertriglyceridemia (HP:0002155) | 1.60586843 |
| 187 | Cervical subluxation (HP:0003308) | 1.60194912 |
| 188 | Lethargy (HP:0001254) | 1.59613581 |
| 189 | Pustule (HP:0200039) | 1.58202787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 3.65989069 |
| 2 | MST4 | 3.52429356 |
| 3 | TSSK6 | 3.19725573 |
| 4 | SCYL2 | 2.65167059 |
| 5 | EIF2AK1 | 2.63411800 |
| 6 | FLT3 | 2.44026379 |
| 7 | PKN2 | 2.40638662 |
| 8 | BCKDK | 2.39816578 |
| 9 | WEE1 | 2.39507622 |
| 10 | BRSK2 | 2.29975774 |
| 11 | TESK2 | 2.27470260 |
| 12 | CDC7 | 2.26677857 |
| 13 | SIK3 | 2.22578557 |
| 14 | ERBB3 | 2.13689877 |
| 15 | TRIB3 | 2.07830756 |
| 16 | MAP4K1 | 2.04754712 |
| 17 | STK10 | 2.04268202 |
| 18 | BCR | 2.01623461 |
| 19 | ACVR1B | 1.98712972 |
| 20 | TAOK3 | 1.97449945 |
| 21 | NME2 | 1.95909110 |
| 22 | MAP2K3 | 1.92489601 |
| 23 | BUB1 | 1.89609956 |
| 24 | IRAK3 | 1.84454230 |
| 25 | RPS6KA4 | 1.79408971 |
| 26 | MAP3K12 | 1.70582266 |
| 27 | LATS1 | 1.70437529 |
| 28 | EIF2AK3 | 1.68777247 |
| 29 | ERN1 | 1.67710282 |
| 30 | FRK | 1.67081990 |
| 31 | EIF2AK2 | 1.61159177 |
| 32 | ZAP70 | 1.56158209 |
| 33 | MKNK2 | 1.56076214 |
| 34 | BMPR2 | 1.55491723 |
| 35 | MAP3K3 | 1.51412986 |
| 36 | EEF2K | 1.50031409 |
| 37 | KDR | 1.47012228 |
| 38 | JAK3 | 1.46713936 |
| 39 | ZAK | 1.46684514 |
| 40 | NEK2 | 1.44539748 |
| 41 | PBK | 1.40911166 |
| 42 | MAP4K2 | 1.37664037 |
| 43 | SIK1 | 1.35418944 |
| 44 | STK3 | 1.32968648 |
| 45 | LRRK2 | 1.32342287 |
| 46 | MAP3K4 | 1.29172608 |
| 47 | TYK2 | 1.27543077 |
| 48 | MAP3K10 | 1.22306686 |
| 49 | BMPR1B | 1.20129904 |
| 50 | PDK2 | 1.19275131 |
| 51 | MAP2K7 | 1.17711935 |
| 52 | FGFR4 | 1.16348907 |
| 53 | ERBB4 | 1.15097156 |
| 54 | PLK2 | 1.13566723 |
| 55 | PIM2 | 1.13058568 |
| 56 | LIMK1 | 1.11745108 |
| 57 | MAP3K8 | 1.09578452 |
| 58 | STK39 | 1.09563247 |
| 59 | GRK1 | 1.09498593 |
| 60 | MAP3K14 | 1.09240996 |
| 61 | RPS6KB2 | 1.08864731 |
| 62 | CLK1 | 1.07059963 |
| 63 | TGFBR1 | 1.06860802 |
| 64 | CDK4 | 1.06609795 |
| 65 | TAF1 | 1.05910001 |
| 66 | TEC | 1.05239794 |
| 67 | VRK1 | 1.03312085 |
| 68 | NEK9 | 1.01611518 |
| 69 | STK38L | 0.99973019 |
| 70 | AURKB | 0.98632724 |
| 71 | PLK1 | 0.98115497 |
| 72 | MST1R | 0.97392071 |
| 73 | VRK2 | 0.93963773 |
| 74 | MAP3K11 | 0.92606795 |
| 75 | PASK | 0.92257458 |
| 76 | PRKCI | 0.91068263 |
| 77 | PIM1 | 0.90883948 |
| 78 | CSNK1A1L | 0.89444856 |
| 79 | TTK | 0.89301445 |
| 80 | MAP3K6 | 0.88924536 |
| 81 | NEK1 | 0.87647710 |
| 82 | CDK7 | 0.85949690 |
| 83 | CSF1R | 0.85861886 |
| 84 | PLK4 | 0.85055120 |
| 85 | STK24 | 0.84709446 |
| 86 | CSNK1G3 | 0.82634551 |
| 87 | STK16 | 0.81958463 |
| 88 | SRPK1 | 0.81421324 |
| 89 | RAF1 | 0.81083563 |
| 90 | ARAF | 0.80171724 |
| 91 | GRK6 | 0.79504438 |
| 92 | TAOK1 | 0.79323225 |
| 93 | AKT3 | 0.79183193 |
| 94 | RIPK1 | 0.78221670 |
| 95 | CDK6 | 0.77061651 |
| 96 | CDK12 | 0.76587381 |
| 97 | CSNK1G1 | 0.74919337 |
| 98 | PAK4 | 0.71063708 |
| 99 | ITK | 0.70627320 |
| 100 | MELK | 0.69744466 |
| 101 | BRAF | 0.68544897 |
| 102 | TBK1 | 0.68046070 |
| 103 | IKBKB | 0.65160055 |
| 104 | ABL2 | 0.64914531 |
| 105 | TXK | 0.64834639 |
| 106 | PAK2 | 0.64026703 |
| 107 | MAPK11 | 0.63794548 |
| 108 | PLK3 | 0.63069621 |
| 109 | MAP3K5 | 0.62528434 |
| 110 | JAK2 | 0.59879915 |
| 111 | TTN | 0.59783889 |
| 112 | DYRK3 | 0.59335712 |
| 113 | KIT | 0.57906846 |
| 114 | RPS6KA5 | 0.57421698 |
| 115 | KSR1 | 0.55936784 |
| 116 | NUAK1 | 0.53677819 |
| 117 | CHEK2 | 0.53634913 |
| 118 | ALK | 0.53234388 |
| 119 | MARK3 | 0.52797212 |
| 120 | CHEK1 | 0.52025157 |
| 121 | BRSK1 | 0.51675319 |
| 122 | CDK8 | 0.51064399 |
| 123 | PIK3CG | 0.49078411 |
| 124 | PDGFRA | 0.48679161 |
| 125 | ATR | 0.48605735 |
| 126 | CSNK1G2 | 0.48219813 |
| 127 | MKNK1 | 0.46901901 |
| 128 | MAPKAPK3 | 0.46887127 |
| 129 | PRKG2 | 0.46504153 |
| 130 | MOS | 0.45748947 |
| 131 | TLK1 | 0.44944219 |
| 132 | LCK | 0.44085538 |
| 133 | TIE1 | 0.43742028 |
| 134 | TGFBR2 | 0.43346020 |
| 135 | DDR2 | 0.42648939 |
| 136 | STK4 | 0.42406686 |
| 137 | BTK | 0.41366198 |
| 138 | AURKA | 0.41209146 |
| 139 | MUSK | 0.40188045 |
| 140 | ATM | 0.39354503 |
| 141 | CCNB1 | 0.38367361 |
| 142 | WNK4 | 0.38003361 |
| 143 | TRPM7 | 0.36526113 |
| 144 | BRD4 | 0.35243844 |
| 145 | MET | 0.33747096 |
| 146 | CHUK | 0.33324055 |
| 147 | CAMKK2 | 0.30020611 |
| 148 | MAPKAPK5 | 0.28673502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.98884847 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.56462208 |
| 3 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.49320736 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.47378822 |
| 5 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.23056565 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.08936267 |
| 7 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.04560393 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.02608838 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01481034 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01080052 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.00548922 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.98112524 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.92389827 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.90356097 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82965211 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79271651 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78591734 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75385667 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63030360 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.62089914 |
| 21 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.60838791 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.58689233 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52531688 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.49524851 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.48025514 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.46056433 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45011099 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.41112436 |
| 29 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.39984846 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.37014636 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35995677 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35214745 |
| 33 | RNA transport_Homo sapiens_hsa03013 | 1.34842865 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.29753231 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28414798 |
| 36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.26884186 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22887333 |
| 38 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.22180391 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21951813 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21386169 |
| 41 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.19793295 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19326804 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16544593 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15482484 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14965935 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14610917 |
| 47 | Ribosome_Homo sapiens_hsa03010 | 1.13474145 |
| 48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.10990673 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09767788 |
| 50 | Proteasome_Homo sapiens_hsa03050 | 1.07979811 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.07839207 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05962675 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.05141682 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01698658 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01238466 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.99526216 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 0.99410218 |
| 58 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98556163 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 0.95598816 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.93460168 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93436287 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92674832 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.92422372 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92283109 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89261814 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89213285 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86875224 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86068189 |
| 69 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.86043246 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85757525 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83661404 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83184259 |
| 73 | Spliceosome_Homo sapiens_hsa03040 | 0.80858500 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80470161 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.79134918 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78825018 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.76071341 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74353181 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73831181 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72427849 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70610913 |
| 82 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69809572 |
| 83 | Protein export_Homo sapiens_hsa03060 | 0.69149225 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68450959 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.68225825 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.68014451 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67226182 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.64479145 |
| 89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63709379 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63455300 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63311712 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.63259417 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62997135 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61183541 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.60776291 |
| 96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.59317002 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58929991 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57974630 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.57004400 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56022609 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55285522 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55075958 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.51831524 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51063108 |
| 105 | Alcoholism_Homo sapiens_hsa05034 | 0.51010417 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.50796650 |
| 107 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49324519 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49211126 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.48595729 |
| 110 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47468820 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40864961 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39762389 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39069821 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37894296 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37890578 |
| 116 | Melanoma_Homo sapiens_hsa05218 | 0.36792661 |
| 117 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36769767 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34449437 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34420964 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34214365 |
| 121 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33779925 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33768457 |
| 123 | Parkinsons disease_Homo sapiens_hsa05012 | 0.33260889 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32983686 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32579570 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.30675796 |
| 127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30110826 |
| 128 | Purine metabolism_Homo sapiens_hsa00230 | 0.29817222 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.29491657 |
| 130 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.29303578 |
| 131 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28428052 |
| 132 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28386112 |
| 133 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.27351203 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21421499 |
| 135 | Phototransduction_Homo sapiens_hsa04744 | 0.20931807 |
| 136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.19843438 |
| 137 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.18181762 |
| 138 | Huntingtons disease_Homo sapiens_hsa05016 | 0.17805261 |
| 139 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.17799898 |
| 140 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15140346 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.13903568 |
| 142 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13849443 |
| 143 | Influenza A_Homo sapiens_hsa05164 | 0.13235725 |
| 144 | Colorectal cancer_Homo sapiens_hsa05210 | 0.12858426 |

